Two Different Blocks for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty

Sponsor
Sisli Hamidiye Etfal Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04286035
Collaborator
(none)
70
1
2
6
11.7

Study Details

Study Description

Brief Summary

The frequency of femoral nerve block and adductor canal block for analgesia after TKA(total knee arthroplasty) increases with the use of ultrasonography in regional anesthesia. In this study, we aimed to compare the effects of femoral nerve block and adductor canal block on postoperative analgesia in patients undergoing unilateral knee arthroplasty.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bupivacaine Injection
  • Drug: Bupivacaine Injection
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Comparison of the Effects of Femoral Nerve Block and Adductor Canal Block on Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty
Actual Study Start Date :
Apr 2, 2019
Actual Primary Completion Date :
Sep 29, 2019
Actual Study Completion Date :
Oct 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Femoral group

Drug: Bupivacaine Injection
Femoral nerve block with 20 ml %0.375 bupivacaine

Active Comparator: Adductor group

Drug: Bupivacaine Injection
Adductor canal block with 20 ml %0.375 bupivacaine

Outcome Measures

Primary Outcome Measures

  1. Tramadol consumption [24 hours after operation]

    Postoperative tramadol consumption with patient controlled analgesia

  2. VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain) [24 hours after operation]

    VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain) is less than four is adequate analgesia

  3. Rescue analgesic requirement [24 hours after operation]

    If VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain) is is four or more, paracetamol 1000 mg is administered

Secondary Outcome Measures

  1. Postoperative nausea and vomiting [24 hours after operation]

    Frequency of postoperative nausea and vomiting

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ASA(American Society of Anesthesiologists) Classification I-II

  • Age: <55 years

  • Unilateral total knee arthroplasty

Exclusion Criteria:
  • Does not approve the study

  • Pregnant

  • Emergency

  • ASA III-IV

  • History of local anesthetic allergy

  • Infection in the block area

  • Coagulation disorder

  • Morbid obesity (body mass index> 40 kg / m²)

  • Severe organ failure

  • Previous neurological deficit

  • Psychiatric disease

  • History of chronic pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 SBÜ Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi Istanbul Turkey

Sponsors and Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kerim Şahin, Research assistant, Sisli Hamidiye Etfal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04286035
Other Study ID Numbers:
  • SK01
First Posted:
Feb 26, 2020
Last Update Posted:
Mar 13, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kerim Şahin, Research assistant, Sisli Hamidiye Etfal Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 13, 2020